Immediate Impact
3 by Nobel laureates 54 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Works of Mélanie Laporte being referenced
Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK -Rearranged Non–Small-Cell Lung Cancer
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Mélanie Laporte | 32 | 93 | 73 | 109 | 97 | 9 | 299 | |
| Mona Ahmed | 27 | 45 | 33 | 126 | 179 | 9 | 322 | |
| Tania B. Porras | 42 | 111 | 36 | 135 | 89 | 16 | 287 | |
| Basira Najafzadeh | 69 | 78 | 35 | 116 | 170 | 10 | 325 | |
| Malin Berglund | 30 | 26 | 35 | 128 | 124 | 15 | 300 | |
| Tingxuan Gu | 33 | 41 | 52 | 84 | 149 | 14 | 258 | |
| Kwok-Wah Chan | 34 | 36 | 32 | 62 | 150 | 9 | 285 | |
| Silvia Mezzalira | 30 | 39 | 20 | 72 | 54 | 8 | 201 | |
| Gongyu Tang | 36 | 91 | 58 | 40 | 220 | 9 | 291 | |
| Stephen Beil | 23 | 26 | 93 | 45 | 102 | 6 | 292 | |
| Dario Lipari | 15 | 36 | 79 | 49 | 50 | 9 | 243 |
All Works
Loading papers...